Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2010-06-29 Regulatory Filings
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Pain Patch Technology Moves Forward 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 30 June 2010 from Phosphagenics Limited regarding the progress of their pain patch technology using TPM transdermal technology. It discusses clinical trial phases, dosing parameters, and future plans for Phase II/III trials. The content is focused on product development updates and clinical trial progress rather than financial results, regulatory filings, or shareholder information. There is no indication of financial statements, earnings data, or regulatory certifications. The document is a corporate announcement about product development progress, which fits best under the category of a general regulatory announcement or company update rather than a financial or governance report. Given the nature and length of the document, and the absence of financial data or meeting-related content, the most appropriate classification is Regulatory Filings (RNS).
2010-06-29 English
Corporate Presentation to BioMelbourne Network 18 pages ?Kb
Investor Presentation Classification · 95% confidence The document is a PowerPoint presentation given by the Joint CEO of Phosphagenics Limited at the BioMelbourne Network breakfast. It contains detailed information about the company's technology, strategic alliances, product launches, and shareholder value creation strategies. The content is typical of an investor-focused presentation, highlighting business strategy, market opportunities, and product details rather than financial statements or regulatory disclosures. There is no indication that this is an annual report, earnings release, or regulatory filing. The presence of slides and the nature of the content align with an Investor Presentation (IP). The document length (8356 characters) supports it being a full presentation rather than a brief announcement or certification. Therefore, the most appropriate classification is Investor Presentation (IP).
2010-06-07 English
Appendix 3Z Final Director`s Interest Notice 3 pages ?Kb
Board/Management Information Classification · 100% confidence The document is an announcement regarding the retirement of a director, Associate Professor Andrew L Vizard, from the board of Phosphagenics Limited. It includes an Appendix 3Z Final Director's Interest Notice, which is a regulatory form used to notify the market of changes in directors' interests and status. The content focuses on the cessation of a director's role and related securities interests, which aligns with announcements about changes in the company's board of directors. There is no financial data, earnings information, or report publication mentioned. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 3595 characters, which is consistent with a detailed announcement rather than a brief notice or report publication announcement.
2010-05-31 English
New Constitution wef 31 May 2010 49 pages ?Kb
Regulatory Filings
2010-05-31 English
Chairman`s and CEO Presentations to Shareholders 20 pages ?Kb
AGM Information Classification · 95% confidence The document is dated 31 May 2010 and is addressed to the ASX Limited Manager Company Announcements Office. It explicitly references the Phosphagenics Limited Annual General Meeting (AGM) and includes the Chairman's address and the Joint CEO's speech to shareholders at the AGM. The content focuses on the company's performance in the previous year, strategic goals, clinical trial progress, licensing, financial position, and management changes, all typical of AGM presentations and materials. There is no indication that this is a full annual report or financial statements, nor is it a brief announcement or voting results. The length (15,000 characters) and detailed content support that this is the presentation material shared at the AGM. Therefore, the document fits the category of AGM Information (AGM-R).
2010-05-30 English
Results of Annual General Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement from Phosphagenics Limited regarding the results of resolutions passed at their Annual General Meeting (AGM) held on 31 May 2010. It details voting outcomes on specific resolutions such as adoption of the Remuneration Report, re-election of a director, and adoption of a new constitution. The document includes proxy voting statistics and confirms that the resolutions were carried. There is no detailed financial data or full report content, only the voting results from the AGM. This matches the description of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is short and focused solely on voting results, not the full AGM materials or annual report.
2010-05-30 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.